Page last updated: 2024-09-05

snc 121 and Glaucoma, Suspect

snc 121 has been researched along with Glaucoma, Suspect in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdul, Y; Akhter, N; Husain, S	1

Other Studies

1 other study(ies) available for snc 121 and Glaucoma, Suspect

Article	Year
Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Investigative ophthalmology & visual science, 2013, Mar-11, Volume: 54, Issue:3 Topics: Animals; Astrocytes; Benzamides; Blotting, Western; Cell Survival; Chronic Disease; Cytoprotection; Disease Models, Animal; Electroretinography; Female; Immunohistochemistry; Injections, Intraperitoneal; Intraocular Pressure; Male; Neuroprotective Agents; Ocular Hypertension; Optic Disk; p38 Mitogen-Activated Protein Kinases; Piperazines; Rats; Rats, Inbred BN; Receptors, Opioid, delta; Retina; Retinal Ganglion Cells; Tumor Necrosis Factor-alpha	2013

Article

Year

Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.

Investigative ophthalmology & visual science, 2013, Mar-11, Volume: 54, Issue:3

Topics: Animals; Astrocytes; Benzamides; Blotting, Western; Cell Survival; Chronic Disease; Cytoprotection; Disease Models, Animal; Electroretinography; Female; Immunohistochemistry; Injections, Intraperitoneal; Intraocular Pressure; Male; Neuroprotective Agents; Ocular Hypertension; Optic Disk; p38 Mitogen-Activated Protein Kinases; Piperazines; Rats; Rats, Inbred BN; Receptors, Opioid, delta; Retina; Retinal Ganglion Cells; Tumor Necrosis Factor-alpha

2013